FRA:BNN • DE0005203947
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BRAIN BIOTECH AG (BNN.DE).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-08-29 | BAADER HELVEA EQUITY RESEARCH | Maintains | Buy -> Buy |
| 2023-08-29 | WARBURG RESEARCH GMBH | Maintains | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 56.225M 11.79% | 55.499M -1.29% | 50.216M -9.52% | 56.358M 12.23% | 69.118M 22.64% | 60.6M -12.32% | 74.576M 23.06% | 81.319M 9.04% | 88.658M 9.02% | 96.591M 8.95% | 104.82M 8.52% | |
| EBITDA YoY % growth | 1.232M 177.00% | -3.92M -418.18% | -2.235M 42.98% | 1.566M 170.07% | 13.332M 751.34% | 5.05M -62.12% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -3.422M 42.39% | -8.743M -155.49% | -7.361M 15.81% | -67.337K 99.09% | 9.696M 14,499.28% | -1.01M -110.42% | 3.372M 433.86% | 4.859M 44.10% | 6.644M 36.74% | 8.727M 31.35% | 11.008M 26.14% | |
| Operating Margin | -6.09% | -15.75% | -14.66% | -0.12% | 14.03% | -1.67% | 4.52% | 5.98% | 7.49% | 9.04% | 10.50% | |
| EPS YoY % growth | N/A -40.41% | N/A 29.19% | N/A 31.93% | -0.27 -39.18% | 0.04 116.05% | -0.23 -630.81% | N/A | N/A | N/A | N/A | N/A |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
9 analysts have analysed BNN.DE and the average price target is 5.34 EUR. This implies a price increase of 98.69% is expected in the next year compared to the current price of 2.69.
BRAIN BIOTECH AG (BNN.DE) will report earnings on 2026-05-28.
The number of analysts covering BRAIN BIOTECH AG (BNN.DE) is 9.